Investigative Ophthalmology & Visual Science Cover Image for Volume 61, Issue 7
June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Amniotic membrane transplantation for treatment of refractory giant papillae and Shield ulcer in vernal keratoconjunctivitis
Author Affiliations & Notes
  • Akanksha Prasad
    Ophthalmology , RML and PGIMER, New Delhi, India
  • Shikha Jain
    Ophthalmology , RML and PGIMER, New Delhi, India
  • Footnotes
    Commercial Relationships   Akanksha Prasad, None; Shikha Jain, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 423. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Akanksha Prasad, Shikha Jain; Amniotic membrane transplantation for treatment of refractory giant papillae and Shield ulcer in vernal keratoconjunctivitis. Invest. Ophthalmol. Vis. Sci. 2020;61(7):423.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To report our experience with amniotic membrane transplantation in the management of severe shield ulcer

Methods : Retrospective, interventional
PARTICIPANTS:
Patient with grade 3 (plaque like lesions) shield ulcers not responding to steroid therapy with or without surgical debridement.
INTERVENTION:
Amniotic membrane transplantation with stromal side down was performed in two layers after meticulous debridement of the ulcer. Bandage contact lens was inserted.

Results : MAIN OUTCOME MEASURES:
Healing of the ulcer with no epithelial defect.
RESULTS:
The ulcer healed with disintegration or retraction of the membrane seen within 2 weeks.

Conclusions : Amniotic membrane transplantation in combination with debridement is an effective surgical modality in the management of severe shield ulcers.
A significant decrease in symptoms and complete re epithelialization of the corneal ulcer was observed within the first 7 days. These remained stable during a mean follow-up of 12 weeks
Patients with severe chronic allergic keratoconjunctivitis benefit from amniotic membrane implantation used as a therapeutic contact lens in the treatment of persistent corneal epithelial defects and vernal plaques unresponsive to conventional medical treatment.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×